Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biopharmx Corp
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biopharmx Corp since year 2005.
Table 2 shows the detailed insider transactions of Biopharmx Corp since 2005.
The reporting company's ticker symbol is BPMX. The reporting company's CIK number is 1504167.
The total value of stock buying since 2005 is $2,141,439.
The total value of stock sales since 2005 is $59,278.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-24||Morlock Stephen (Director)||Buy||330,000||.15||49,500|
|2017-11-09||Vivo Capital Viii, Llc||Sale||296,394||.20||59,278|
|2017-08-01||Franklin Resources Inc (10% Owner)||Buy||250,000||.34||84,250|
|2017-04-28||Vivo Capital Fund Viii, L.p.||Buy||1,282,052||.78||1,000,000|
|2016-11-22||Franklin Resources Inc (10% Owner)||Buy||4,375,000||.00||0|
|2016-08-15||Franklin Resources Inc (10% Owner)||Buy||484,615||.65||314,999|
|2016-03-29||Franklin Resources Inc (10% Owner)||Buy||540,000||1.20||648,000|
|2016-01-14||Morlock Stephen (Director)||Buy||5,500||1.53||8,415|
|2016-01-13||Morlock Stephen (Director)||Buy||6,500||1.52||9,880|
|2016-01-12||Morlock Stephen (Director)||Buy||3,000||1.63||4,890|
|2016-01-11||Morlock Stephen (Director)||Buy||3,000||1.43||4,290|
|2016-01-07||Morlock Stephen (Director)||Buy||5,000||1.47||7,350|
|2015-10-15||Morlock Stephen (Director)||Buy||3,000||1.23||3,690|
|2015-10-14||Morlock Stephen (Director)||Buy||2,000||1.25||2,500|
|2015-10-09||Morlock Stephen (Director)||Buy||3,000||1.23||3,675|
Insider trading activities including stock purchases, stock sales, and option exercises of BPMX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biopharmx Corp (symbol BPMX, CIK number 1504167) see the Securities and Exchange Commission (SEC) website.